follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Celegene gets FDA approval for Revlimid

By

Back to Top Comments Email Print

News You Can Use

Latest News

advertisement

Celgene Corp. on Wednesday announced it won Food and Drug Administration approval for Revlimid, a treatment for certain patients with mantle cell lymphoma.

According to a news release from Celgene, in Summit, the drug is approved for patients whose disease has relapsed or progressed after two prior therapies.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top